Is the End of the Obesity Epidemic Near?
3 Articles
3 Articles
If you thought that Ozempic was the panacea to lose weight without moving a finger, get ready to release a tear: Eli Lilly just pulled out retatrutide, a molecule that fulminates all previous records. The number hurts—for those who sell it as a magic injection, of course—: a 30.3% weight loss in 104 weeks, three times what single-receptor agonists offer. The clinical trial, called TRIUMPH-1, has been designed to measure the efficacy and safety o…
Retatrutide Drives Major Weight-Loss Results
The race to develop more effective obesity treatments has entered a new phase. Retatrutide, a next-generation experimental weight-loss drug, has delivered remarkable clinical trial results. Researchers found that participants lost nearly one-third of their body weight during the study. As a result, the drug is gaining attention across the healthcare and pharmaceutical industries. Obesity affects millions of people worldwide. It also increases th…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
